Response to: 'Correspondence on 'Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management'' by Snarskaya and Vasileva.

Bruni, Cosimo; Matucci-Cerinic, Marco

Bruni, Cosimo; Matucci-Cerinic, Marco.

Bruni C; Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze, Italy.
Matucci-Cerinic M; Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze, Italy marco.matuccicerinic@unifi.it.

Ann Rheum Dis ; 2021 Jan 06.

Article in English | MEDLINE | ID: covidwho-2253154

Keywords

COVID-19; biological therapy; scleroderma; systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-219533

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-219533